Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)

This study is currently recruiting participants.

Verified April 2013 by Washington University School of Medicine

Study NCT01065129 Information provided by Washington University School of Medicine

First Received on February 5, 2010. Last Updated on April 24, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Preleukemia

More general conditions related to this trial

Interventions listed in this trial

G-CSF
Plerixafor
Azacitidine

Additional drug interventions recognized in this trial

JM 3100
Lenograstim

More general drug interventions related to this trial

Sponsors listed in this trial